|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01513 LIVZON PHARMA
Nominal 
26.300 -0.200 (-0.755%) Profitability Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| ROAA (%) | 7.828% | 8.084% | 8.266% | 8.893% | 7.358% |
| ROAE (%) | 13.995% | 14.207% | 14.143% | 14.737% | 11.943% |
| Return on Capital Employed (%) | 11.521% | 10.929% | 11.495% | 11.821% | 10.273% |
Margin Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Gross Profit Margin (%) | -- | -- | -- | -- | -- |
| EBITDA Margin (%) | 23.657% | 21.269% | 21.618% | 26.684% | 20.597% |
| Pre-tax Profit Margin (%) | 19.169% | 18.453% | 18.615% | 23.663% | 18.408% |
| Net Profit Margin (%) | 15.717% | 15.119% | 14.719% | 16.301% | 13.883% |
Liquidity Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Current Ratio (X) | 2.135 X | 2.297 X | 2.119 X | 2.405 X | 2.432 X |
| Quick Ratio (X) | 1.880 X | 2.020 X | 1.879 X | 2.160 X | 2.211 X |
Leverage Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Total Liabilities / Total Assets(%) | 41.039% | 39.938% | 36.031% | 33.756% | 31.715% |
| Total Debt / Total Assets (%) | 16.536% | 14.552% | 12.044% | 9.373% | 7.570% |
| Net Debt / Total Assets (%) | -28.685% | -27.314% | -28.840% | -38.968% | -41.691% |
| Total Debt / Shareholders' Funds (%) | 29.493% | 26.079% | 20.720% | 15.940% | 12.187% |
| Long Term Debt / Shareholders' Funds (%) | 11.549% | 14.313% | 4.937% | 3.060% | 0% |
| Net Debt / Shareholders' Funds (%) | -51.161% | -48.952% | -49.616% | -66.273% | -67.115% |
| Net Cash / (Debt) ($) | 7.184B | 6.793B | 6.452B | 8.024B | 7.495B |
| Net Cash / (Debt) per share ($) | 7.776 | 7.261 | 6.879 | 8.492 | 8.018 |
| Total Debt / Capital Employed (%) | 24.423% | 20.712% | 17.443% | 13.302% | 10.730% |
| Interest Coverage Ratio (X) | 24.340 X | 24.892 X | 27.735 X | 99.345 X | 239.117 X |
Efficiency Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Inventory Turnover (Day) | -- | -- | -- | -- | -- |
| Receivables Turnover (Day) | 111.793 Day | 105.965 Day | 93.581 Day | 92.244 Day | 94.053 Day |
| Payables Turnover (Day) | 51.688 Day | 53.167 Day | 52.071 Day | 50.097 Day | 50.911 Day |
| Remarks: | Real time quote last updated: 14/11/2024 14:57 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,170,971 |
| %Change | 3.208% |
| EPS / (LPS) | RMB 1.270 |
| NBV Per Share (¥) | RMB 15.027 |